十年努力为作者争取著作权认可——为何仍需继续努力
A ten-year drive to credit authors for their work — and why there’s still more to do
#Published online#build trust#research assessment#ten-year drive#responsible research
生命科学资讯
生物技术与制药领域的最新动态
合成舌头评估辣椒辣度，解放人类品尝者
Synthetic tongue rates chillies’ heat — and spares human tasters
#Published online#tasters Nature#November#doi#Synthetic tongue
将自然纳入资产负债表：如何核算我们行为的生态成本
Putting nature on the balance sheet: how to account for the ecological costs of our actions
#Published online#Putting nature#balance sheet#actions Nature#ecological costs
氢燃料并非总是绿色之选
Hydrogen fuel isn’t always the green choice
#Published online#choice Nature#direct electrification#Hydrogen fuel#green choice
面具与玛雅：书籍简评
Of masks and Mayans: Books in brief
#Published online#Robinson reviews#science picks#November#doi
追逐小龙虾及其身上的蚂蟥
Chasing crayfish and the leeches that live on them
#Published online#Shrestha works#Chasing crayfish#crayfish symbionts#evolutionary history
如何拆除定时炸弹
How to defuse a time bomb
#Published online#bomb Nature#November#doi#progression
摩根士丹利因增长前景将龙沙集团股票评级上调至增持
Morgan Stanley upgrades Lonza Group stock to Overweight on growth outlook By Investing.com - Investing.com South Africa
2025年11月25日融资信息
Financings for Nov. 25, 2025
2025年11月25日门诊安排
In the clinic for Nov. 25, 2025
2025年11月25日其他值得关注新闻
Other news to note for Nov. 25, 2025
2025年11月25日监管动态
Regulatory actions for Nov. 25, 2025
Protara因二期数据强劲，在LM领域看到中外制药的蓝天前景。
Protara sees Chugai blue sky in LMs as phase II data strong
诺华获准对年长患者使用脊髓性肌萎缩基因疗法
Novartis wins approval to use SMA gene therapy in older patients
FDA批准Sarepta采用Elevidys进行新型免疫抑制方法研究；吉利德收购临床前TREX1项目
FDA OKs Sarepta study of new immune suppression approach with Elevidys; Gilead buys preclinical TREX1 program
吉利德收购一项临床前癌症研究项目
Gilead scoops up a preclinical cancer program
大型药企员工如何评价他们的CEO？
How do Big Pharma employees rate their CEOs?
科伦、默克力推ADC药物作为肺癌一线治疗新选择
Kelun, Merck tout ADC as potential first-line treatment in lung cancer
凯瑟琳·M·罗什讣告 - 爱国者纪事报
Kathleen M. Roche Obituary - The Patriot Ledger
安捷伦科技股价创52周新高，达153.85美元——投资网报道
Agilent Technologies stock hits 52-week high at 153.85 USD - Investing.com